Market Indices
Sector Heatmap
ETON — Eton Pharmaceutcials, Inc. Common Stock
NasdaqEton Pharmaceutcials, Inc. Common Stock
- O
- 52.42
- H
- 56.00
- L
- 52.00
- V
- 673K
ETON — Latest News & Headlines
20 StoriesETON Stock Rises as Eton Pharmaceuticals Secures Impavido Rights - timothysykes.com
ETON Stock Rises as Eton Pharmaceuticals Secures Impavido Rights timothysykes.com
$ETON stock is down 15% today. Here's what we see in our data. - quiverquant.com
$ETON stock is down 15% today. Here's what we see in our data. quiverquant.com
Eton Pharmaceuticals (NASDAQ:ETON) Stock Price Down 7.4% - Here's Why - MarketBeat
Eton Pharmaceuticals (NASDAQ:ETON) Stock Price Down 7.4% - Here's Why MarketBeat
Eligible commercially insured patients have a $0 copay option for IMPAVIDO. Eton has launched it in the U.S. - stocktitan.net
Eligible commercially insured patients have a $0 copay option for IMPAVIDO. Eton has launched it in the U.S. stocktitan.net
Eton Pharmaceuticals (NASDAQ:ETON): High Growth Momentum Meets a Breakout Setup - ChartMill
Eton Pharmaceuticals (NASDAQ:ETON): High Growth Momentum Meets a Breakout Setup ChartMill
Understanding Momentum Shifts in (ETON) - Stock Traders Daily
Understanding Momentum Shifts in (ETON) Stock Traders Daily
How IMPAVIDO Rights Deal At Eton Pharmaceuticals (ETON) Has Changed Its Investment Story - Simply Wall Street
How IMPAVIDO Rights Deal At Eton Pharmaceuticals (ETON) Has Changed Its Investment Story Simply Wall Street
Eton Pharmaceuticals Inc (ETON) Shares Fall 13.0% -- What GF Sco - GuruFocus
Eton Pharmaceuticals Inc (ETON) Shares Fall 13.0% -- What GF Sco GuruFocus
Eton Pharmaceuticals Relaunches IMPAVIDO for Rare Leishmaniasis Treatment - The Globe and Mail
Eton Pharmaceuticals Relaunches IMPAVIDO for Rare Leishmaniasis Treatment The Globe and Mail
Eton Pharmaceuticals (NASDAQ:ETON) Stock Price Up 5.9% - Should You Buy? - MarketBeat
Eton Pharmaceuticals (NASDAQ:ETON) Stock Price Up 5.9% - Should You Buy? MarketBeat
ETON270219P00025000 Interactive Stock Chart | ETON Feb 2027 25.000 put Stock - Yahoo! Finance Canada
ETON270219P00025000 Interactive Stock Chart | ETON Feb 2027 25.000 put Stock Yahoo! Finance Canada
Eton Pharmaceuticals (ETON) Moved, What Is Behind The Fresh Attention? - Simply Wall Street
Eton Pharmaceuticals (ETON) Moved, What Is Behind The Fresh Attention? Simply Wall Street
Is Eton Pharmaceuticals Inc (ETON) Overvalued After 7.0% Rally? - GuruFocus
Is Eton Pharmaceuticals Inc (ETON) Overvalued After 7.0% Rally? GuruFocus
ETON Jumps As Eton Pharmaceuticals Relaunches Impavido In U.S. - timothysykes.com
ETON Jumps As Eton Pharmaceuticals Relaunches Impavido In U.S. timothysykes.com
Eton Pharmaceuticals Launches IMPAVIDO in the U.S. with Expanded Patient Support and Specialty Pharmacy Access - quiverquant.com
Eton Pharmaceuticals Launches IMPAVIDO in the U.S. with Expanded Patient Support and Specialty Pharmacy Access quiverquant.com
Bank of America Corp DE Acquires New Shares in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Bank of America Corp DE Acquires New Shares in Eton Pharmaceuticals, Inc. $ETON MarketBeat
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Receives Average Recommendation of "Moderate Buy" from Analysts MarketBeat
Rapport Therapeutics (Nasdaq:RAPP) - Stock Analysis - Simply Wall Street
Rapport Therapeutics (Nasdaq:RAPP) - Stock Analysis Simply Wall Street
Eton Pharmaceuticals Announces U.S. Commercial Availability of IMPAVIDO® (miltefosine) Capsules - marketscreener.com
Eton Pharmaceuticals Announces U.S. Commercial Availability of IMPAVIDO® (miltefosine) Capsules marketscreener.com
YPF investors ask US Supreme Court to revive $16.1 billion judgment against Argentina - The Mighty 790 KFGO
YPF investors ask US Supreme Court to revive $16.1 billion judgment against Argentina The Mighty 790 KFGO